Stay updated on Nivolumab in Advanced Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced Colon Cancer Clinical Trial page.

Latest updates to the Nivolumab in Advanced Colon Cancer Clinical Trial page
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check50 days agoChange DetectedThe page has removed a significant study reference regarding Nivolumab in colorectal cancer, which may impact the information available to readers about treatment options.SummaryDifference0.4%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check86 days agoChange DetectedThe page has been updated to include new drug information, specifically Daratumumab and BMS-986016, while significant details about the Nivolumab study and its criteria have been removed.SummaryDifference12%
Stay in the know with updates to Nivolumab in Advanced Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Colon Cancer Clinical Trial page.